V. McGuire

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

Yurii B. Shvetsov, Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, 2016, Oncotarget.